Isaac Melamed

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Richard Dodel, Axel Rominger, Peter Bartenstein et al. · The Lancet Neurology · 2013 · 185 citations

Medicine, Neurology, Pharmacotherapy +11

Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency

Richard L. Wasserman, Isaac Melamed, Mark R. Stein et al. · Journal of Allergy and Clinical Immunology · 2012 · 149 citations · Full text

Life Sciences, Biotechnology, Immunology +13

Benefit of ketotifen in patients with eosinophilic gastroenteritis

Isaac Melamed, Stephen Feanny, Philip M. Sherman et al. · The American Journal of Medicine · 1991 · 139 citations

Medicine, Pharmacology, Pharmacotherapy +11

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

John B. Hagan, Mary Beth Fasano, Sheldon Spector et al. · Journal of Clinical Immunology · 2010 · 131 citations · Full text

Life Sciences, Immunology, Pharmacology +16